DIRLOC
Spark Therapeutics, Inc.
The mark consists of the word "DIRLOC" in stylized purple lettering. The letter "I" represents a double helix in the colors purple, teal, and red. The color white represents background and transparent areas and is not part of the mark.
Mark For: DIRLOC™ trademark registration is intended to cover the categories of
>The color(s) purple, teal, and red is/are claimed as a feature of the mark. The mark consists of the word DIRLOC in upper case lettering in the color purple. The letter I represents a double helix in the colors purple, teal, and red.
| Research |
OneLook
Acronym Finder
|
| Serial Number | 97795321 |
| Mark Literal Elements | DIRLOC |
| Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S) |
| Mark Type | SERVICE MARK |
| Standard Character Claim | No |
| Register | PRINCIPAL |
| Current Location | INTENT TO USE SECTION 2023-12-26 |
| Basis | 1(b) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | No |
| Intent To Use | Yes |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Susan A. Smith |
| Attorney Docket Number | 00400829 |
Timeline
| 2023-02-15 | Application Filed |
| 2023-02-18 | Location: NEW APPLICATION PROCESSING |
| 2023-02-18 | Status: Live/Pending |
| 2023-02-18 | Transaction Date |
| 2023-10-31 | Published |
| 2023-12-26 | Location: INTENT TO USE SECTION |
| 2023-12-26 | Status: Notice of Allowance (NOA) sent (issued) to the applicant. Applicant must file a Statement of Use or Extension Request within six |
Trademark Parties (Applicants & Owners)
| Party: |  Spark Therapeutics, Inc. |
| Address | 3737 Market Street, Suite 1300 Philadelphia, PENNSYLVANIA UNITED STATES 19104 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Application | 2023-02-15 | |
| Drawing | 2023-02-15 | |
| Design Search Code Corr Project | 2023-03-07 | |
| XSearch Search Summary | 2023-06-17 | |
| Examiner's Amendment | 2023-09-26 | |
| Amendment and Mail Process Complete | 2023-09-27 | |
| TRAM Snapshot of App at Pub for Oppostn | 2023-09-27 | |
| Notice of Publication | 2023-10-11 | |
| Notification Of Notice of Publication | 2023-10-11 | |
| OG Publication Confirmation | 2023-10-31 | |
| Notice of Allowance | 2023-12-26 |
Design Search Codes
| 26.01.29 | DNA helix; Helixes |
| 27.03.05 | Objects forming letters or numerals |
| 260129 | DNA helix; Helixes |
| 270305 | Objects forming letters or numerals |
Attorney of Record
Good, Services, and Codes
IC 042. US 100 101. G & S: Providing medical research information in the field of clinical trials in relation to hemophilia; medical research in the field of hemophilia
| International Codes: | 42 |
| U.S. Codes: | 100,101 |
| Type Code | Type |
|---|---|
| DM0000 | The mark consists of the word DIRLOC in upper case lettering in the color purple. The letter I represents a double helix in the colors purple, teal, and red. |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2023-12-26 | |
| PUBLISHED FOR OPPOSITION | 2023-10-31 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2023-10-31 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2023-10-11 | |
| NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | 2023-09-26 | |
| EXAMINERS AMENDMENT E-MAILED | 2023-09-26 | |
| EXAMINERS AMENDMENT -WRITTEN | 2023-09-26 | |
| EXAMINER'S AMENDMENT ENTERED | 2023-09-26 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2023-09-26 | |
| ASSIGNED TO EXAMINER | 2023-06-10 | |
| NOTICE OF DESIGN SEARCH CODE E-MAILED | 2023-03-07 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2023-03-05 | |
| NEW APPLICATION ENTERED | 2023-02-18 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 DIRLOC 97795321 not registered Live/Pending |
Spark Therapeutics, Inc. 2023-02-15 |
 DIRLOC 97795318 not registered Live/Pending |
Spark Therapeutics, Inc. 2023-02-15 |
 DIRLOC 97795316 not registered Live/Pending |
Spark Therapeutics, Inc. 2023-02-15 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 